Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

Introducing eConnext™: The Next Generation of Online Conference Engagement

TORONTO, CANADA, June 8, 2018— Six Degrees Medical (SDM) announces the launch of eConnext™. eConnext™ combines SDM’s medical writing and pharmaceutical industry content development experience with state-of-the-art virtual meeting platforms...

Six Degrees Medical Consulting

- PMLiVE

Roche’s MabThera ends drug drought for serious skin disease

As biosimilars seize market share, Roche finds ways to extend blockbuster's revenues

- PMLiVE

If you’re going global, go local and go early

A brief arrives in your inbox. You have been asked to develop an integrated communications plan for a global healthcare company. A plan that builds disease awareness, establishes unmet needs,...

- PMLiVE

Daily Brief: Keytruda and microbiome synergy, Pfizer’s files PARP contender and more

Your daily injection of pharma news

- PMLiVE

Merck’s Brexit contingency plan? Stockpile medicines

As UK's Brexit plans remain in disarray, big pharma is making contingency plans

- PMLiVE

Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

Orphan drug sales growth will be 11%+ a year

- PMLiVE

Aptar Pharma advances digital offerings

Partners up with digital therapeutics company Propeller Health

- PMLiVE

Communications in a mobile age

mHealth: when will pharma catch up?

- PMLiVE

Behavioural insights to navigate complex healthcare markets

Blue Latitude Health Head of Insight Martine Leroy reveals how her team uses behavioural insights to help develop strong pharma brands and services, which successfully navigate complex situations.

Blue Latitude Health

- PMLiVE

Axovant bets on gene therapy with $842.5m Oxford BioMedica deal

Big departure from repurposing - Spark's Fraser Wright comes on board

- PMLiVE

Daily Brief:  NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal

All the latest from the frontlines of healthcare

- PMLiVE

Keytruda cleared for frontline lung cancer in England – but only after another pricing deal

Keytruda first drug to exit Cancer Drugs Fund and go through Budget Impact Test

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links